Concepedia

Danai Daliani

DD

Statistics

Publications

37

Citations

4.6K

H-Index

23

Active since

1995

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University Hospital of Larissa

University of Thessaly

Spanish Oncology Genitourinary Group

Athens Euroclinic

Danai Daliani is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and urology.

Top concepts

Publications per year

1995–2024

37

Publications

37

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Glenn J. Bubley, Michael A. Carducci, William L. Dahut et al. · Journal of Clinical Oncology · 1999 · 979 citations

Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer

Christos N. Papandreou, Danai Daliani, Darrell Nix et al. · Journal of Clinical Oncology · 2004 · 436 citations · Full text

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

Shi‐Ming Tu, Randall E. Millikan, Bayabel Mengistu et al. · The Lancet · 2001 · 395 citations

, , +8

Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study

Lance C. Pagliaro, Dallas Williams, Danai Daliani et al. · Journal of Clinical Oncology · 2010 · 386 citations · Full text

Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial

Michael A. Carducci, Robert J. Padley, Jürgen Breul et al. · Journal of Clinical Oncology · 2003 · 370 citations

Rows per page

1–5 of 37